Incyte Is Undervalued - Cramer's Lightning Round (2/22/17)

|
Includes: AMD, EXEL, FCX, GILD, HBAN, HCA, INCY, KEY, MET, MU, SAM, STZ, SWKS, WDC
by: SA Editor Mohit Manghnani

Summary

Western Digital is a buy.

Stay long on Skyworks Solutions.

Gilead Sciences need to use their cash in a better way.

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, February 22.

Bullish Calls

Western Digital (NYSE:WDC): "I really have to tell you I don't think we are at peak margins. I know Western Digital has come in. Actually I am a buyer of Western Digital here. My charitable trust is thinking about buying it."

MetLife (NYSE:MET): The stock is not coming down despite downgrade. Book partial profits and let the rest run.

Incyte Corporation (NASDAQ:INCY): It has a great pipeline and makes a lot of money. It's an undervalued stock.

Freeport-McMoRan (NYSE:FCX): "It was looking great before this Indonesian deal, but I think you're fine."

Skyworks Solutions (NASDAQ:SWKS): They are having a great year. Stay long.

Advanced Micro Devices (NASDAQ:AMD): It's a good play on PCs. Cramer likes Micron Technology (NASDAQ:MU) as well.

Neutral Call

HCA Holdings (NYSE:HCA): It should come down due to repeal of Obamacare but it isn't. Cramer doesn't want to buy or sell it.

Bearish Calls

Huntington Bancshares (NASDAQ:HBAN): KeyCorp (NYSE:KEY) is the stock to buy when it comes to Ohio banks.

Exelixis (NASDAQ:EXEL): The stock is good but it has run up a lot. It cannot be bought at these levels.

Boston Beer (NYSE:SAM): No. Cramer likes Constellation Brands.

Gilead Sciences (NASDAQ:GILD): They have to do something with their cash. It's a value trap.

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Jim Cramer's Action Alerts PLUS: Check out Cramer's multi-million dollar charitable trust portfolio and uncover the stocks he thinks could be HUGE winners. Start your FREE 14-day trial now!

Get Cramer's Picks by email - it's free and takes only a few seconds to sign up.

About this article:

Expand
Want to share your opinion on this article? Add a comment.
Disagree with this article? .
To report a factual error in this article, click here